Now Enrolling: How to Qualify
You may be eligible to participate in GATHER2 if you have been diagnosed with geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD). Learn about GA associated with AMD.
If you are interested in participating in the GATHER2 Clinical Trial, a clinical trial staff member will help determine if you are eligible to participate when you call.
ZIMURA® IS AN INVESTIGATIONAL PRODUCT AND HAS NOT BEEN APPROVED BY THE FDA. SAFETY AND EFFICACY OF ZIMURA® FOR AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY HAVE NOT BEEN ESTABLISHED. PLEASE SPEAK TO YOUR DOCTOR ABOUT PARTICIPATING IN THIS TRIAL.
Zimura® (avacincaptad pegol) is a registered trademark of IVERIC bio, Inc.